Integra LifeSciences Holdings Corp. Company Profile (NASDAQ:IART)

Analyst Ratings

Consensus Ratings for Integra LifeSciences Holdings Corp. (NASDAQ:IART) (?)
Ratings Breakdown: 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $81.13 (3.73% downside)

Analysts' Ratings History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetActions
7/29/2016Jefferies GroupBoost Price TargetBuy$81.00 -> $95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2016Barclays PLCBoost Price TargetEqual Weight$77.00 -> $84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2016JPMorgan Chase & Co.Initiated CoverageOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2016Piper Jaffray Cos.Reiterated RatingOverweight$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Lake Street CapitalBoost Price TargetHold$57.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015Citigroup Inc.Initiated CoverageBuy$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/21/2015Bank of America Corp.UpgradeNeutral -> Buy$72.00 -> $79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Raymond James Financial Inc.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Royal Bank Of CanadaBoost Price TargetSector Perform$62.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015ArgusBoost Price TargetBuy$61.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
7/28/2016Q216$0.76$0.79$243.17 million$249.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2016Q116$0.73$0.74$230.66 million$236.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q4$0.86$0.87$241.11 million$241.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315$0.74$0.75$224.08 million$226.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.75$0.79$239.91 million$244.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$0.63$0.76$229.69 million$233.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414$0.89$0.94$244.39 million$252.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2014Q314$0.74$0.76$233.50 million$229.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$0.64$0.68$229.32 million$231.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$0.58$0.57$213.30 million$215.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2012$0.77$0.85ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012$0.69$0.74ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2012$0.60$0.71ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012$0.55$0.72ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2011$0.77$0.77ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011$0.61$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$0.66$0.66ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2011$0.73$0.80ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Integra LifeSciences Holdings Corp. (NASDAQ:IART)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$0.72$0.85$0.78
Q2 20164$0.76$0.85$0.80
Q3 20164$0.87$0.90$0.89
Q4 20165$0.97$1.06$1.02
Q1 20172$0.86$0.86$0.86
Q2 20172$0.83$0.89$0.86
Q3 20172$0.84$1.01$0.93
Q4 20172$0.96$1.16$1.06
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/9/2016Joseph VinhaisVPSell972$73.36$71,305.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016Glenn ColemanCFOSell3,563$70.62$251,619.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2016Christian S SchadeDirectorSell7,829$70.42$551,318.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Daniel L ReuversVPSell1,000$71.43$71,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Richard D GorelickVPSell4,000$70.72$282,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Stuart EssigDirectorSell104,390$70.15$7,322,958.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Stuart EssigDirectorSell21,100$66.19$1,396,609.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/5/2016Stuart EssigDirectorSell83,290$66.68$5,553,777.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Stuart EssigDirectorSell42,150$67.26$2,835,009.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015Stuart EssigDirectorSell75,000$64.32$4,824,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2015Stuart EssigDirectorSell125,000$64.83$8,103,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Judith OgradyVPSell3,500$53.33$186,655.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014Stuart EssigDirectorSell147,098$49.58$7,293,118.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014Stuart EssigDirectorSell41,268$49.56$2,045,242.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Judith OgradyVPSell2,500$49.82$124,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Richard D GorelickVPSell7,000$50.03$350,210.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014John B Henneman IIICAOSell20,000$50.12$1,002,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Deborah A LeonettiVPSell1,000$50.96$50,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2014Brian LarkinVPSell1,947$48.28$94,001.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Stuart EssigDirectorSell50,800$47.76$2,426,208.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2014Stuart EssigDirectorSell27,819$47.80$1,329,748.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Judith OgradyVPSell2,500$47.54$118,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2014Stuart EssigDirectorSell21,381$47.76$1,021,156.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/3/2014Stuart EssigDirectorSell6,344$46.01$291,887.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2014Stuart EssigDirectorSell76,177$46.05$3,507,950.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2014Stuart EssigDirectorSell17,479$46.05$804,907.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Deborah LeonettiVPSell7,563$49.22$372,250.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Integra LifeSciences Holdings Corp. (NASDAQ:IART)
DateHeadline
07/30/16 04:03 PMIntegra LifeSciences Holdings Reaches Analyst Target Price
07/30/16 04:03 PMIntegra Lifesciences Holdings Corp. (NASDAQ:IART) stock price target bumped up to $84 as reported today by Barclays Capital
07/28/16 07:32 AMINTEGRA LIFESCIENCES HOLDINGS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
07/28/16 07:32 AMIntegra LifeSciences Raises 2016 Revenue Guidance
07/28/16 07:32 AMIntegra Lifesciences Holdings Corp Q2 Profit Rises 21%
07/28/16 07:32 AMIntegra LifeSciences Holdings Corporation: Integra LifeSciences Reports Second Quarter 2016 Financial Results
07/28/16 06:07 AMQ2 2016 Integra LifeSciences Holdings Corp Earnings Release - Before Market Open -
07/28/16 05:25 AMIntegra beats Street 2Q forecasts -
07/13/16 04:55 PMIntegra LifeSciences Holdings Corporation (IART) Hits New 52-week High During July 11 Session
07/11/16 03:33 PMIntegra LifeSciences to Host Its Second Quarter 2016 Earnings Results Conference Call on July 28, 2016 - [at noodls] - July 11, 2016 PLAINSBORO, N.J., July 11, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its second quarter 2016 financial results on Thursday, July 28, 2016. ...
07/09/16 07:57 AMIntegra LifeSciences Holdings Corporation (IART) Hits New 52-week High During July 07 Session
07/05/16 09:00 AMIntegra LifeSciences Holdings Corporation (Nasdaq: IART) to Ring The Nasdaq Stock Market Closing Bell - [GlobeNewswire] - What: Integra LifeSciences Holdings Corporation, a leading global medical technology company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Glenn G. Coleman, Chief Financial ...
07/04/16 07:32 AMIntegra LifeSciences at 52-Week High on Solid Q1 Results -
07/03/16 04:08 PMIntegra LifeSciences Holdings Corporation (IART) Hits New 52-week High During June 30 Session
06/28/16 09:28 AMIntegra LifeSciences Holdings Larger Than S&P 500 Component Chesapeake Energy
06/16/16 02:09 AMIntegra LifeSciences to Hold First International Tissue Technologies Symposium on June 16 - 17, 2016 in Lisbon, Portugal - [at noodls] - June 16, 2016 PLAINSBORO, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it is holding its first International Symposium on Tissue ...
06/12/16 07:18 AMIntegra LifeSciences Holdings Corporation (IART) Hits New 52-week High During June 09 Session
06/10/16 04:41 PMIntroducing Dentsply Sirona, a Leading Dental Products Manufacturer
06/05/16 04:30 PMIntegra LifeSciences Holdings Corporation (IART) Hits New 52-week High During June 02 Session
05/31/16 04:44 PMShares Touching a Recent High: Integra LifeSciences Holdings Corporation (NASDAQ:IART) - The EPS growth for the past five (5) years shows a value of 19.70%, whilst the EPS value for the next five (5) years shows a figure of 16.82%. Company shares were Reiterated by Canaccord Genuity on April 27, 2016 to "Buy", Firm has raised the Price Target ...
05/30/16 11:52 AMAfter Last Week What Do Analysts Think Of Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Share Trading News - After Last Week What Do Analysts Think Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)Share Trading News11/11/2013 – Integra LifeSciences Holdings Corporation was upgraded to “equal weight” by analysts at Morgan Stanley. They now have a USD 40 price target on the stock. The share price of Integra LifeSciences Holdings Corporation (NASDAQ:IART) was up ...and more »
05/29/16 11:04 AMIntegra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased By 9.86% - HNN - Integra Lifesciences Holdings Corporation (NASDAQ:IART) Shorted Shares Increased By 9.86%HNNThe stock of Integra Lifesciences Holdings Corporation (NASDAQ:IART) registered an increase of 9.86% in short interest. IART's total short interest was 3.17M shares in May as published by FINRA. Its up 9.86% from 2.88M shares, reported previously.Integra LifeSciences Holdings Corporation (NASDAQ:IART) Quarterly EPS From Continuing Operations Stands At $0.32Enterprise LeaderMitsubishi Ufj Securities Holdings Ltd. adds Integra Lifesciences Holdings Corp (IART) to its portfolioMarket DigestIntegra LifeSciences Holdings Corporation (NASDAQ:IART) Closes At $73.11Vanguard TribuneThe News Journal -Risers & Fallers -CCH Daily Newsall 10 news articles »
05/28/16 08:40 AM8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls -
05/26/16 03:16 PMINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/26/16 10:23 AMIntegra LifeSciences Holdings Corp (IART) Hits New 52-week High During May 23 Session - Equities.com - Integra LifeSciences Holdings Corp (IART) Hits New 52-week High During May 23 SessionEquities.comIntegra LifeSciences Holdings Corp (IART) hit a new 52-week high yesterday, reaching a peak of $74.49 after opening at $72.76 and closing at $71.86 for a move of -0.8%. Hitting a new 52-week high is a notable milestone for any company, and it can mean ...and more »
05/25/16 03:26 PMIntegra LifeSciences to Present at the Jefferies 2016 Healthcare Conference in June 2016 - [at noodls] - May 25, 2016 PLAINSBORO, N.J., May 25, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in June: At 8:30AM ...
05/23/16 07:36 AMIntegra LifeSciences launches Integra® Fin-Lock™ Glenoid for the Titan™ Modular Shoulder System - [at noodls] - May 23, 2016 PLAINSBORO, N.J., May 23, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of the Integra® ...
05/11/16 07:30 AMIntegra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release - [GlobeNewswire] - PLAINSBORO, N.J., May 11, 2016-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, today announced that the Company has received approval from the U.S. Food and Drug ...
05/03/16 03:20 PMIntegra LifeSciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference and the UBS Global Healthcare Conference in May 2016 - [at noodls] - May 3, 2016 PLAINSBORO, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in May: At 1:00PM ...
05/03/16 12:04 PMINTEGRA LIFESCIENCES HOLDINGS CORP Financials -
05/02/16 12:13 PMIntegra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/28/16 12:36 PMIntegra (IART) Beats on Q1 Earnings, Grows Organically -
04/27/16 03:57 PMEdited Transcript of IART earnings conference call or presentation 27-Apr-16 12:30pm GMT -
04/27/16 06:07 AMQ1 2016 Integra LifeSciences Holdings Corp Earnings Release - Before Market Open -
04/27/16 05:18 AMIntegra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch - [at noodls] - April 27, 2016 PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company ...
04/27/16 05:09 AMIntegra beats Street 1Q forecasts -
04/09/16 01:24 PMIntegra LifeSciences Holdings Corporation (NASDAQ:IART): Earnings In Focus - Investor Newswire - Integra LifeSciences Holdings Corporation (NASDAQ:IART): Earnings In FocusInvestor NewswireFollowing the recent poll, Integra LifeSciences Holdings Corporation (NASDAQ:IART) can post EPS of $0.84 in the upcoming results, which can be disclosed anytime around 2016-05-05. The earnings target released by Thomson Reuter's may vary from EPS ...and more »
04/09/16 01:24 PMEarnings View for Integra LifeSciences Holdings Corporation (NASDAQ:IART) - RiversideGazette.com - Earnings View for Integra LifeSciences Holdings Corporation (NASDAQ:IART)RiversideGazette.comWall Street analysts have a current quarter EPS estimate of $0.73 on shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be released ...and more »
04/06/16 03:27 PMIntegra LifeSciences to Host Its First Quarter 2016 Earnings Results Conference Call on April 27, 2016 - [at noodls] - April 6, 2016 PLAINSBORO, N.J., April 06, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its first quarter 2016 financial results on Wednesday, April 27, ...
03/15/16 12:10 PMEarnings Quick Look: Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Business Standard Tribune - Earnings Quick Look: Integra LifeSciences Holdings Corporation (NASDAQ:IART)Business Standard TribuneWall Street sell-side analysts are projecting that Integra LifeSciences Holdings Corporation (NASDAQ:IART) will post earnings of $0.73 per share for the current quarter. This is the Zack's Research consensus number which might slightly vary from other ...and more »
03/10/16 07:30 AMIntegra LifeSciences Awarded $10.3 Million Department of Defense Contract - [GlobeNewswire] - PLAINSBORO, N.J., March 10, 2016-- Integra LifeSciences Holding Corporation, a leading global medical technology company, today announced that through its partnership with Buffalo Supply, it has received ...
02/29/16 10:03 AMIntegra LifeSciences Holdings Corp. Earnings Analysis: 2015 By the Numbers -
02/26/16 05:29 PMINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 10-K, Annual Report -
02/26/16 08:29 AMIntegra LifeSciences Announces Service Alliance Agreement With PREZIO Health - GlobeNewswire (press release) - Integra LifeSciences Announces Service Alliance Agreement With PREZIO HealthGlobeNewswire (press release)PLAINSBORO, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (NASDAQ:IART) today announced its service alliance agreement with PREZIO Health, a leader in perioperative services, repair, maintenance and ...
02/26/16 08:29 AMEARNINGS SUMMARY: Details of Integra Lifesciences Holdings Corp Q4 Earnings Report - Below are the earnings highlights for Integra Lifesciences Holdings Corp (IART): -Earnings: $32.76 million in Q4 vs. $30.57 million in the same period last year. -EPS: $0.87 in Q4 vs. $0.92 in the same period last year. -Analysts projected $0.86 per share ...
02/25/16 11:11 PMEdited Transcript of IART earnings conference call or presentation 25-Feb-16 9:30pm GMT -
02/25/16 03:34 PMIntegra beats Street 4Q forecasts -
02/25/16 03:30 PMIntegra LifeSciences Announces Service Alliance Agreement With PREZIO Health - [GlobeNewswire] - PLAINSBORO, N.J., Feb. 25, 2016-- Integra LifeSciences Holding Corporation today announced its service alliance agreement with PREZIO Health, a leader in perioperative services, repair, maintenance and ...
02/25/16 03:05 PM4:05 pm Integra beats by $0.01, reports revs in-line; guides FY16 EPS in-line, revs above consensus -
02/25/16 03:01 PMIntegra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance - [GlobeNewswire] - Fourth Quarter Revenues Increased 10.1% to $241.2 Million Fourth Quarter Adjusted EPS of $0.87; Reported EPS of $0.39 Full Year Organic Revenues Increased 6.7%. PLAINSBORO, N.J., Feb. 25, 2016-- Integra ...

Social

About Integra LifeSciences Holdings Corp.

Integra LifeSciences Holdings Corp. logoIntegra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties. Its product category includes products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care, including product portfolios used in neurosurgery operation suites and critical care units, and Orthopedics and Tissue Technologies, which offers products of a combination of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement hardware products for both upper extremities and lower extremities.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: IART
  • CUSIP: 45798520
Key Metrics:
  • Previous Close: $84.27
  • 50 Day Moving Average: $78.62
  • 200 Day Moving Average: $69.16
  • P/E Ratio: 427.77
  • P/E Growth: 2.00
  • Market Cap: $3.14B
  • Beta: 0.63
  • Current Year EPS Consensus Estimate: $3.45 EPS
  • Next Year EPS Consensus Estimate: $3.91 EPS
Additional Links:
Integra LifeSciences Holdings Corp. (NASDAQ:IART) Chart for Saturday, July, 30, 2016